Electromed (ELMD) Net Shares Issued and Repurchased (2011 - 2026)
Electromed's (ELMD) quarterly Net Shares Issued and Repurchased came in at $58500.0 in Q2 2026, down 6.3% year-over-year from $62432.0 in Q2 2025, and little changed quarter-over-quarter from $58500.0 in Q3 2025.
Powered by 
Analysis
Electromed (ELMD) Net Shares Issued and Repurchased (2011 - 2026) Analysis & Trends
Electromed (ELMD) has reported Net Shares Issued and Repurchased for 16 consecutive years, with $58500.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Shares Issued and Repurchased fell 6.3% year-over-year to $58500.0 in Q2 2026; TTM through Jun 2026 was $58500.0, a 6.3% decrease from a year earlier, with the FY2026 full-year figure at $58500.0, down 6.3% from the prior year.
- Net Shares Issued and Repurchased was $58500.0 for Q2 2026 at Electromed, roughly flat from $58500.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $263162.0 in Q2 2024 and troughed at $58500.0 in Q3 2025.
- A 5-year average of $128986.9 and a median of $101500.0 in 2022 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased soared 152.25% in 2024 and tumbled 76.28% in 2025, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $101500.0 in 2022, then surged by 151.79% to $255562.0 in 2023, then plunged by 31.52% to $175000.0 in 2024, then slumped by 66.57% to $58500.0 in 2025, then changed by 0.0% to $58500.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $58500.0 (Q2 2026), $58500.0 (Q3 2025), and $62432.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Electromed | 222.94 Mn | 202.49 Mn | 15.28 Mn | 58,500.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58,500.00 |
| Sep 30, 2025 | 58,500.00 |
| Jun 30, 2025 | 62,432.00 |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | 263,162.00 |
| Sep 30, 2023 | 255,562.00 |
| Jun 30, 2023 | 104,325.00 |
| Sep 30, 2022 | 101,500.00 |
| Jun 30, 2022 | 81,901.00 |
| Sep 30, 2021 | 70,800.00 |
| Jun 30, 2021 | 112,598.00 |
| Sep 30, 2020 | 56,898.00 |
| Jun 30, 2020 | 149,300.00 |
| Sep 30, 2019 | 149,300.00 |
| Jun 30, 2019 | 333,117.00 |
| Sep 30, 2018 | 181,250.00 |
| Jun 30, 2018 | 201,250.00 |
| Sep 30, 2017 | 182,250.00 |
| Jun 30, 2017 | 176,500.00 |
| Sep 30, 2016 | 176,500.00 |